Proteins related to the spindle and checkpoint mitotic emphasize the different pathogenesis of hypoplastic MDS

Area of Science:

• Molecular Biology
• Oncology
• Hematology

Background:

• Alterations in mitotic spindle and checkpoint proteins (AURORAS KINASE A/B, CDC20, MAD2L1) are implicated in chromosomal instability and tumor progression.
• These proteins play a role in various solid and hematologic malignancies, suggesting potential involvement in myelodysplastic syndromes (MDS).

Purpose of the Study:

• To evaluate the expression and amplification of AURORA KINASE A (AURKA), AURORA KINASE B (AURKB), CDC20, and MAD2L1 genes in patients with MDS.
• To investigate the association of these genes with clinical parameters and disease progression in MDS.

Main Methods:

• Analysis of 61 bone marrow samples from MDS patients.
• Cytogenetic analysis using G-banding.
• Fluorescence in situ hybridization (FISH) for AURKA and AURKB amplification.
• Quantitative real-time polymerase chain reaction (qRT-PCR) for gene expression analysis.

Main Results:

• AURKA gene amplification was observed in 10% of MDS cases, with significantly higher expression levels compared to controls (p=0.038).
• Higher AURKA expression was found in normo/hypercellular bone marrow (BM) compared to hypocellular BM.
• Logistic regression revealed that high expression levels of AURKA were associated with an increased risk of developing normo/hypercellular MDS.
• Age was associated with high expression levels of AURKA, CDC20, and MAD2L1.

Conclusions:

• Amplification and high expression of AURKA suggest its potential role in the pathogenesis of MDS.
• Bone marrow cellularity is an important prognostic factor in MDS, as indicated by distinct gene expression patterns.
• Age is a significant factor associated with the expression of key cell cycle regulatory genes in MDS.